In addition, as DPB1*0501, which M41 peptide binds to, is frequently expressed in Japanese population (approximately 60%), it is expected that our defined helper peptide would contribute to the tumour immunotherapy of patients with MAGE-A4-expressing tumour. Here, MAGEA4 is linked to neoplasm.